SALL4 and breast cancer: Some studies have suggested that SALL4 silencing in Dox BC resistance cell lines reverts the resistance through cell cycle arrest and downregulation of membrane transporter ABCG2, more commonly referred to as BCRP (breast cancer resistance protein) [17] and nuclear receptor-binding protein 1 (NRBP1) [19].